147 related articles for article (PubMed ID: 15664302)
21. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
DiBernardi L; Doré M; Davis JA; Owens JG; Mohammed SI; Guptill CF; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):245-50. PubMed ID: 17383864
[TBL] [Abstract][Full Text] [Related]
22. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
23. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53.
Landolfi JA; Terio KA
Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444
[TBL] [Abstract][Full Text] [Related]
24. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
[TBL] [Abstract][Full Text] [Related]
25. Bradykinin stimulates prostaglandin E2 production and cyclooxygenase activity in equine nonglandular and glandular gastric mucosa in vitro.
Morrissey NK; Bellenger CR; Baird AW
Equine Vet J; 2008 Jun; 40(4):332-6. PubMed ID: 18331972
[TBL] [Abstract][Full Text] [Related]
26. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.
Klein RD; Van Pelt CS; Sabichi AL; Dela Cerda J; Fischer SM; Fürstenberger G; Müller-Decker K
Cancer Res; 2005 Mar; 65(5):1808-13. PubMed ID: 15753378
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects.
Mohammed SI; Dhawan D; Abraham S; Snyder PW; Waters DJ; Craig BA; Lu M; Wu L; Zheng R; Stewart J; Knapp DW
Mol Cancer Ther; 2006 Feb; 5(2):329-36. PubMed ID: 16505106
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
Bourn J; Cekanova M
Drug Des Devel Ther; 2018; 12():1727-1742. PubMed ID: 29942116
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
[TBL] [Abstract][Full Text] [Related]
30. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells.
Park C; Kim GY; Kim GD; Choi BT; Park YM; Choi YH
Oncol Rep; 2006 May; 15(5):1225-31. PubMed ID: 16596191
[TBL] [Abstract][Full Text] [Related]
31. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.
Smakman N; Schaap N; Snijckers CM; Borel Rinkes IH; Kranenburg O
Urology; 2005 Aug; 66(2):434-40. PubMed ID: 16098373
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclooxygenase-2 in canine nasal carcinomas.
Impellizeri JA; Esplin DG
Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
35. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.
Mohammed SI; Knapp DW; Bostwick DG; Foster RS; Khan KN; Masferrer JL; Woerner BM; Snyder PW; Koki AT
Cancer Res; 1999 Nov; 59(22):5647-50. PubMed ID: 10582676
[TBL] [Abstract][Full Text] [Related]
37. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclooxygenase-2, P-glycoprotein and multi-drug resistance-associated protein in canine transitional cell carcinoma.
Lee JY; Tanabe S; Shimohira H; Kobayashi Y; Oomachi T; Azuma S; Ogihara K; Inokuma H
Res Vet Sci; 2007 Oct; 83(2):210-6. PubMed ID: 17316722
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
